IMMVF
Price
$0.15
Change
-$0.02 (-11.76%)
Updated
Feb 8 closing price
Capitalization
14.59M
Intraday BUY SELL Signals
LZAGY
Price
$67.05
Change
-$0.28 (-0.42%)
Updated
Feb 3 closing price
Capitalization
46.98B
71 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMMVF vs LZAGY

Header iconIMMVF vs LZAGY Comparison
Open Charts IMMVF vs LZAGYBanner chart's image
Immunovia AB
Price$0.15
Change-$0.02 (-11.76%)
Volume$325
Capitalization14.59M
Lonza Group AG
Price$67.05
Change-$0.28 (-0.42%)
Volume$38.85K
Capitalization46.98B
IMMVF vs LZAGY Comparison Chart in %
IMMVF
Daily Signal:
Gain/Loss:
LZAGY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IMMVF vs. LZAGY commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMMVF is a Hold and LZAGY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (IMMVF: $0.02 vs. LZAGY: $67.05)
Brand notoriety: IMMVF and LZAGY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IMMVF: 120% vs. LZAGY: 54%
Market capitalization -- IMMVF: $14.59M vs. LZAGY: $46.98B
IMMVF [@Medical Specialties] is valued at $14.59M. LZAGY’s [@Medical Specialties] market capitalization is $46.98B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $12.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMMVF’s FA Score shows that 0 FA rating(s) are green whileLZAGY’s FA Score has 1 green FA rating(s).

  • IMMVF’s FA Score: 0 green, 5 red.
  • LZAGY’s FA Score: 1 green, 4 red.
According to our system of comparison, LZAGY is a better buy in the long-term than IMMVF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMMVF’s TA Score shows that 2 TA indicator(s) are bullish while LZAGY’s TA Score has 5 bullish TA indicator(s).

  • IMMVF’s TA Score: 2 bullish, 3 bearish.
  • LZAGY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, LZAGY is a better buy in the short-term than IMMVF.

Price Growth

IMMVF (@Medical Specialties) experienced а 0.00% price change this week, while LZAGY (@Medical Specialties) price change was -7.85% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.33%. For the same industry, the average monthly price growth was -0.33%, and the average quarterly price growth was +22.90%.

Reported Earning Dates

LZAGY is expected to report earnings on Apr 16, 2026.

Industries' Descriptions

@Medical Specialties (-4.33% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LZAGY($47B) has a higher market cap than IMMVF($14.6M). IMMVF YTD gains are higher at: 0.000 vs. LZAGY (-0.208). LZAGY has higher annual earnings (EBITDA): 1.05B vs. IMMVF (-57.94M). LZAGY has more cash in the bank: 907M vs. IMMVF (26.6M). IMMVF has less debt than LZAGY: IMMVF (20.4M) vs LZAGY (4.61B). LZAGY has higher revenues than IMMVF: LZAGY (7.09B) vs IMMVF (786K).
IMMVFLZAGYIMMVF / LZAGY
Capitalization14.6M47B0%
EBITDA-57.94M1.05B-6%
Gain YTD0.000-0.208-
P/E RatioN/A40.19-
Revenue786K7.09B0%
Total Cash26.6M907M3%
Total Debt20.4M4.61B0%
FUNDAMENTALS RATINGS
IMMVF vs LZAGY: Fundamental Ratings
IMMVF
LZAGY
OUTLOOK RATING
1..100
156
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
18
Undervalued
PROFIT vs RISK RATING
1..100
10092
SMR RATING
1..100
10092
PRICE GROWTH RATING
1..100
9656
P/E GROWTH RATING
1..100
10090
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LZAGY's Valuation (18) in the null industry is somewhat better than the same rating for IMMVF (73). This means that LZAGY’s stock grew somewhat faster than IMMVF’s over the last 12 months.

LZAGY's Profit vs Risk Rating (92) in the null industry is in the same range as IMMVF (100). This means that LZAGY’s stock grew similarly to IMMVF’s over the last 12 months.

LZAGY's SMR Rating (92) in the null industry is in the same range as IMMVF (100). This means that LZAGY’s stock grew similarly to IMMVF’s over the last 12 months.

LZAGY's Price Growth Rating (56) in the null industry is somewhat better than the same rating for IMMVF (96). This means that LZAGY’s stock grew somewhat faster than IMMVF’s over the last 12 months.

LZAGY's P/E Growth Rating (90) in the null industry is in the same range as IMMVF (100). This means that LZAGY’s stock grew similarly to IMMVF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMMVFLZAGY
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
53%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
18%
Bearish Trend 2 days ago
59%
MACD
ODDS (%)
Bullish Trend 2 days ago
25%
Bearish Trend 2 days ago
56%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
7%
Bearish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
2%
Bearish Trend 2 days ago
57%
Advances
ODDS (%)
N/A
Bullish Trend 24 days ago
55%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
56%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
69%
Aroon
ODDS (%)
Bearish Trend 2 days ago
11%
Bullish Trend 2 days ago
51%
View a ticker or compare two or three
Interact to see
Advertisement
IMMVF
Daily Signal:
Gain/Loss:
LZAGY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTNA33.290.20
+0.60%
Artesian Resources Corp
BLUWU10.52N/A
N/A
Blue Water Acquisition Corp. III
RMTI1.12-0.02
-1.75%
Rockwell Medical
PCVX55.73-1.67
-2.91%
Vaxcyte
OCS28.15-0.88
-3.03%
Oculis Holding AG

IMMVF and

Correlation & Price change

A.I.dvisor tells us that IMMVF and IDTA have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMMVF and IDTA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMVF
1D Price
Change %
IMMVF100%
N/A
IDTA - IMMVF
8%
Poorly correlated
N/A
LZAGF - IMMVF
8%
Poorly correlated
-2.11%
LZAGY - IMMVF
6%
Poorly correlated
-1.47%
IVF - IMMVF
4%
Poorly correlated
-6.45%
IOBCF - IMMVF
0%
Poorly correlated
N/A
More

LZAGY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LZAGY has been loosely correlated with LZAGF. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if LZAGY jumps, then LZAGF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LZAGY
1D Price
Change %
LZAGY100%
-1.47%
LZAGF - LZAGY
62%
Loosely correlated
-2.11%
TMO - LZAGY
42%
Loosely correlated
-2.01%
SOAGY - LZAGY
41%
Loosely correlated
+7.02%
CRL - LZAGY
37%
Loosely correlated
-5.54%
DHR - LZAGY
36%
Loosely correlated
-3.05%
More